These drugs lower your hormone levels or block the estrogen from acting on the cancer cells. This then slows or stops the growth of tumors. Not all forms of breast cancer have hormone receptors.

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...